![]() |
市場調查報告書
商品編碼
1447107
2030 年普通手術器械市場預測:按產品類型、技術、應用、最終用戶和地區進行的全球分析General Surgical Devices Market Forecasts to 2030 - Global Analysis By Product, Type, Technology, Application, End User and by Geography |
根據 Stratistics MRC 的數據,2023 年全球普通手術器材市場規模為 174.4 億美元,預計預測期內年複合成長率為 10.39%,到 2030 年將達到 348.4 億美元。
在現代醫療保健系統中,普通手術設備是幫助外科醫生快速且準確地執行各種任務的重要工具。手術刀、鑷子、剪刀、牽開器和止血鉗等器械都包含在這一類中,因為它們旨在促進外科手術。此外,技術進步使得機器人輔助手術系統和腹腔鏡器械等微創手術器械的侵入性更小,縮短了恢復時間,並改善了病患的治療效果。
根據美國外科醫生學會的說法,手術技術的進步以及最尖端科技與普通手術設備的整合有助於改善患者的治療效果、促進創新並提高整個醫學界的手術護理標準。
慢性病增加和人口老化
普通手術器械市場的主要促進因素是癌症、心血管疾病和整形外科疾病等慢性疾病的盛行率不斷上升。隨著世界人口老化,人們因老齡化相關的健康問題而需要手術介入的可能性也在增加。這些人口變化和慢性病的流行正在推動對普通手術設備的需求。此外,這些設備的範圍從傳統器械到支援複雜外科手術的最尖端科技。
高成本和財務限制
尖端手術技術的高價格是普通手術設備市場的主要障礙。對於醫療機構來說,購買和實施機器人手術系統等尖端設備的初始成本可能令人望而卻步。此外,預算限制限制了這些技術在已開發市場和新興市場的採用,這可能會阻礙整體市場的成長。為了應對這項挑戰,製造商和醫療保健提供者必須平衡成本效益和創新。
微創手術的需求不斷增加
由於微創手術方法的趨勢日益增強,普通手術器械市場預計將顯著成長。更快的恢復時間、更少的術後疼痛以及更短的住院時間都是微創手術的好處。此外,為促進微創手術而創建的專用儀器和設備的市場不斷成長,患者意識的提高和對這些手術的需求正在刺激創新和市場成長。
嚴格的法規環境
收緊法規可能導致新器械核准延遲,對普通手術器械市場構成威脅。製造商在滿足不斷變化的監管要求方面面臨挑戰,這可能會延遲新產品的發布並增加滿足監管要求的成本。此外,嚴格遵守法規雖然對於確保病人安全是必要的,但也帶來了可能阻礙新手術器械及時推出的風險。
普通手術器械市場受到 COVID-19 大流行的嚴重擾亂,對供需雙方都產生了影響。特別是在大流行初期,由於選擇性手術被推遲或取消,手術器械的使用減少了。 COVID-19 病例的優先順序和資源的重新分配使醫療機構難以繼續正常業務。此外,製造延誤、供應鏈中斷和物流限制也阻礙了市場。然而,隨著醫療保健系統適應新規範並優先恢復擇期手術,疫情後期出現了緩慢但穩定的復甦。
預計腹腔鏡手術設備領域在預測期內將是最大的。
腹腔鏡器械在一般外科器械市場中佔有最大的市場佔有率,對於微創手術治療至關重要。這些器械包括最尖端科技,如相機、氣腹和腹腔鏡手術中使用的專用器械,以最大限度地減少患者創傷並創造更小的切口。此外,由於住院時間較短、術後疼痛較少和恢復時間較短,患者對微創手術的偏好增加,從而推動了對腹腔鏡設備的需求。改進的可視化和精確度可幫助外科醫生更有效地完成工作並造福患者。
預計神經外科領域在預測期內將經歷最高的年複合成長率。
神經外科領域具有強勁且動態的發展軌跡,預計在普通手術器械市場中擁有最高的年複合成長率。神經外科技術和儀器的技術發展以及神經系統疾病盛行率的增加增加了對專用儀器和設備的需求。由於機器人輔助神經外科系統、神經刺激設備和微創手術等技術創新,這一領域正在迅速擴大。此外,由於人口老化和對神經系統疾病認知的提高,對神經外科設備的需求也在增加。
由於其複雜的醫療保健系統、強力的法規結構以及需要手術干涉的慢性疾病的高盛行率,北美目前佔據普通外科設備的最大市場佔有率。該地區的主導地位歸功於對促進創新和採用尖端外科技術的研發的大量投資。普通手術器械的普及是由行業巨頭的存在和強大的報銷結構所推動的。此外,人口老化和對微創手術日益成長的需求正在推動北美該市場的成長。
預計普通手術器械市場將以亞太地區最高年複合成長率成長,反映出醫療保健系統的快速變化。這一顯著成長歸因於多種因素,包括慢性病盛行率增加、醫療支出增加以及中國和印度等國家衛生基礎設施的發展。該地區人口眾多且老化,增加了對外科手術的需求,並推動了最先進的普通外科設備的使用。此外,對醫療保健現代化和最尖端科技整合的關注也推動了該市場的發展。
According to Stratistics MRC, the Global General Surgical Devices Market is accounted for $17.44 billion in 2023 and is expected to reach $34.84 billion by 2030 growing at a CAGR of 10.39% during the forecast period. In the modern healthcare system, general surgical instruments are essential tools that help surgeons execute a variety of tasks quickly and precisely. Devices such as scalpels, forceps, scissors, retractors, and hemostats are included in this category because they are made to make surgical procedures easier. Moreover, with less invasiveness, faster recovery periods, and better patient outcomes, minimally invasive surgical devices, such as robotic-assisted surgical systems and laparoscopic instruments, have been made possible by technological advancements.
According to the American Surgical Association, advancements in surgical techniques and the integration of cutting-edge technologies in general surgical devices have significantly contributed to improving patient outcomes, fostering innovation, and elevating the standards of surgical care across the medical landscape.
Growing chronic illness prevalence and aging population
The primary driver of the general surgical device market is the increasing prevalence of chronic diseases, including cancer, cardiovascular disorders, and orthopedic conditions. The probability of individuals needing surgical interventions for age-related health issues is increasing as the world's population ages. The need for general surgical devices is fueled by this shift in the population as well as the prevalence of chronic illnesses. Additionally, these devices can range from conventional instruments to cutting-edge technologies that support complex surgical procedures.
Expensive expenses and financial limitations
The high price of cutting-edge surgical technologies is a major barrier to the market for general surgical devices. For healthcare facilities, the upfront costs associated with acquiring and deploying state-of-the-art equipment, like robotic surgical systems, can be prohibitive. Furthermore, the limited adoption of these technologies due to budgetary constraints in developed and developing regions could potentially hinder the overall growth of the market. To meet this challenge, manufacturers and healthcare providers must strike a balance between cost-effectiveness and innovation.
Growing requirement for less invasive surgery
The market for general surgical devices is poised for substantial growth due to the growing inclination towards minimally invasive surgical methods. Fewer recovery periods, less pain following surgery, and shorter hospital stays are all advantages of minimally invasive procedures. Moreover, a growing market exists for specialized tools and devices made to facilitate minimally invasive surgeries, which is stimulating innovation and market growth as patient awareness and demand for these procedures increase.
Strictly regulated environment
Stricter regulations that may cause delays in the approval of new devices pose a threat to the market for general surgical devices. Manufacturers face difficulties adhering to changing regulatory requirements, which can cause delays in the launch of new products and escalate the expenses related to fulfilling regulatory requirements. Additionally, strict adherence to regulations is necessary to ensure patient safety, but it also poses a risk to the timely release of novel surgical devices.
The market for general surgical devices has been severely disrupted by the COVID-19 pandemic, affecting both the supply and demand sides. Especially in the early stages of the pandemic, a decrease in the use of surgical devices resulted from the postponement or cancellation of elective surgeries. Because of the prioritization of COVID-19 cases and the reallocation of resources, healthcare facilities encountered difficulties in continuing their regular operations. Further impeding the market were delays in manufacturing, disruptions in the supply chain, and logistical limitations. However, as healthcare systems adjusted to new standards and the resumption of elective surgeries was prioritized, the later stages of the pandemic saw a slow but steady recovery.
The Laproscopic Devices segment is expected to be the largest during the forecast period
With the largest market share in the general surgical devices market, laparoscopic instruments are essential to minimally invasive surgical treatments. These gadgets include cutting-edge technologies like cameras, insufflators, and specialty tools used in laparoscopic procedures, which minimize patient trauma and allow for smaller incisions. Moreover, laparoscopic device demand has been driven by patients increasing preference for minimally invasive procedures because of their shorter hospital stays, reduced postoperative pain, and faster recovery times. Improved visualization and precision help surgeons perform their jobs more effectively, which benefits patients.
The Neurosurgery segment is expected to have the highest CAGR during the forecast period
With a strong and dynamic trajectory, the neurosurgery segment is expected to have the highest CAGR in the general surgical device market. The need for specialized tools and equipment is driven by the rising incidence of neurological disorders as well as technological developments in neurosurgical techniques and apparatus. The field is expanding quickly due to innovations like robotic-assisted neurosurgery systems, neurostimulation devices, and minimally invasive procedures. Additionally, the need for neurosurgical devices is also fueled by an aging population and increased awareness of neurological disorders.
Due to its sophisticated healthcare system, solid regulatory framework, and high incidence of chronic illnesses requiring surgical interventions, North America presently commands the largest market share for general surgical devices. Large investments in R&D, which promote innovation and the adoption of state-of-the-art surgical technologies, are credited with the region's dominance. The widespread use of general surgical devices is facilitated by the existence of major industry participants and a strong reimbursement structure. Furthermore, the aging population and the rising need for minimally invasive surgical procedures are driving the growth of this market in North America.
The general surgical devices market is expected to grow at the highest CAGR in the Asia-Pacific region, reflecting the rapidly changing nature of the healthcare system. This remarkable rise is being fueled by a number of factors, including the growing incidence of chronic illnesses, rising healthcare spending, and developing healthcare infrastructure in nations like China and India. Due to the regions large and aging population, there is an increasing need for surgical procedures, which is encouraging the use of cutting-edge general surgical instruments. Additionally, the market is advanced by the emphasis on modernizing healthcare and the integration of cutting-edge technologies.
Key players in the market
Some of the key players in General Surgical Devices market include B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, 3M Healthcare, Cadence Inc, Boston Scientific Corporation, Cook Medical Inc., Dickinson and Company, Abbott Laboratories, Siemens Healthcare GmbH, Johnson & Johnson Service Inc., Becton, Integra LifeSciences, Conmed Corporation, Hoffmann-La Roche, Stryker Corporation, Erbe Elektromedizin Gmbh, Zimmer Biomet Holdings, Inc. and Teleflex Incorporated.
In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch(R) device - a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology(TM) algorithm and next-generation continuous glucose monitor (CGM), is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.
In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.
In July 2023, Cadence Design Systems, Inc. and Rambus Inc., a premier chip and silicon IP provider making data faster and safer, today announced that they have entered into a definitive agreement for Cadence to acquire the Rambus SerDes and memory interface PHY IP business. Rambus will retain its digital IP business, including memory and interface controllers and security IP.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.